Cell Line & Method to Minimize the Occurrence of RCA
Qbiogene has introduced two new services from its Merlin® Custom Services division to aid scientists involved in functional genomics, gene delivery and gene therapy research: an E1-complementing cell line and a method (US patent 5,891,690) that minimize the production of Replication Competent Adenoviruses (RCA) and a new highly sensitive assay (patent pending) for the detection of RCA in viral preparations.
As a division of Qbiogene, Merlin® Custom Services offers expertise in various technologies and high capacity production facilities for molecular biology, protein purification, immunology and gene and cell therapy. The company’s complete range of services ensures that customers receive the highest quality service in the shortest possible time.
As with all Qbiogene products, the new Adenovirus Preparations and RCA Assay are competitively priced, available for immediate shipment, and backed by comprehensive technical support. For more information, visit the Qbiogene website at: www.qbiogene.com, e-mail firstname.lastname@example.org, call toll-free at 1-888-362-5487, or write Qbiogene, Inc., 1801 de Maisonneuve Blvd, Suite 800, Montreal, Quebec, H2H 1J9 Canada.